Skip to content

Clinical study for ''Shuang-Shen San-Jie'' Formula in the prevention and treatment of postoperative recurrence of Glioblastoma

Clinical study for ''Shuang-Shen San-Jie'' Formula in the prevention and treatment of postoperative recurrence of Glioblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003185
Enrollment
Unknown
Registered
2020-04-05
Start date
2020-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged from 18 to 70 years old; 2. Patients with definite pathological diagnosis and newly diagnosed GBM; 3. Totally resected tumor evaluated by MRI within 1 month after operation; 4. KPS score >=60; 5. Voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with serious diseases of heart, liver, kidney and hematopoietic system; 2. Patients known to be allergic to research medications; 3. Children, pregnant women, mental patients and patients with other malignant tumors; 4. Patients undergoing other drug trials; 5. There are obvious factors affecting oral drug absorption, such as inability to swallow, intestinal obstruction and so on.

Design outcomes

Primary

MeasureTime frame
DFS;

Secondary

MeasureTime frame
Quality of life score;OS;KPS score;

Countries

China

Contacts

Public ContactYinggang Qin

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

theoldq@126.com+86 10-88001388

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026